Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity
Acetylshikonin, a natural naphthoquinone derivative compound, has been used for treatment of inflammation and cancer. In the present study, we have investigated whether acetylshikonin could regulate the NF-κB signaling pathway, thereby leading to suppression of tumorigenesis. We observed that acetyl...
Main Authors: | Cho, Seok-Cheol, Choi, Bu Young |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Society of Applied Pharmacology
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556202/ |
Similar Items
-
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus
by: LIU, LING, et al.
Published: (2013) -
Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1)
by: Zhu, Xiang-Yu, et al.
Published: (2012) -
THE PANC 3 SCORE PREDICTING SEVERITY OF ACUTE
PANCREATITIS
by: BEDUSCHI, Murilo Gamba, et al.
Published: (2016) -
The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice
by: Liu, C, et al.
Published: (2015) -
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB
by: Giles, Keith M., et al.
Published: (2016)